RMFCX
Price
$64.34
Change
+$0.28 (+0.44%)
Updated
Sep 3 closing price
Net Assets
117.86B
TGDVX
Price
$17.38
Change
+$0.08 (+0.46%)
Updated
Sep 2 closing price
Net Assets
569.84M
Interact to see
Advertisement

RMFCX vs TGDVX

RMFCX vs TGDVX Comparison Chart in %
View a ticker or compare two or three
VS
RMFCX vs. TGDVX commentary
Sep 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RMFCX is a Buy and TGDVX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 118B vs. TGDVX (570M). RMFCX pays higher dividends than TGDVX: RMFCX (1.15) vs TGDVX (1.01). RMFCX was incepted earlier than TGDVX: RMFCX (24 years) vs TGDVX (29 years). TGDVX (1.02) is less costly to investors than RMFCX (0.91). TGDVX is a more actively managed with annual turnover of: 61.97 vs. RMFCX (30.00). RMFCX has a lower initial minimum investment than TGDVX: RMFCX (250) vs TGDVX (2000). RMFCX annual gain was more profitable for investors over the last year : 8.40 vs. TGDVX (3.47). RMFCX return over 5 years is better than : 34.96 vs. TGDVX (20.88).
RMFCXTGDVXRMFCX / TGDVX
Total Expense Ratio0.910.85107%
Annual Report Gross Expense Ratio0.911.0289%
Fund Existence24 years29 years-
Gain YTD9.99216.97159%
Front LoadN/AN/A-
Min. Initial Investment250200013%
Min. Initial Investment IRAN/AN/A-
Net Assets118B570M20,702%
Annual Yield % from dividends1.151.01114%
Returns for 1 year8.403.47242%
Returns for 3 years36.1131.01116%
Returns for 5 years34.9620.88167%
Returns for 10 years92.03-13.32-691%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BNS93.312.12
+2.32%
Bank of Nova Scotia
JSPR0.700.01
+1.05%
Jasper Therapeutics
NTWO10.890.01
+0.09%
Newbury Street II Acquisition Corp
COGT34.57-0.11
-0.32%
Cogent Biosciences
MLTX15.06-0.07
-0.46%
MoonLake Immunotherapeutics